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The atypical PKC isoforms, PKMζ and PKCλ have been proposed as integral substrates
of long-term memory (LTM). Inhibition of these isoforms has recently been demonstrated
to be sufficient for impairing the expression and maintenance of long-term potentiation.
Additionally, the pseudosubstrate inhibitor, zeta inhibitory peptide (ZIP), which effectively
blocks PKMζ and PKCλ, has previously been shown to disrupt associative memory; very
little is known about its effects on pathological nonassociative forms of memory related
to addiction. The neural and molecular substrates of memory and addiction have recently
been argued to overlap. Here, we used ZIP to disrupt PKMζ and PKCλ activity to examine
their role in cocaine sensitization, a nonassociative, addiction-related memory argued to
underlie the transition from casual to pathological drug use. We examined the effects of
both continuous and acute administration of ZIP. Even a single application of ZIP blocked
the development of sensitization; sustained inhibition using osmotic pumps produced
an almost complete blockade of sensitization. Further, a single application of ZIP was
shown to reduce membrane-bound AMPAR expression. These results demonstrate a
novel, critical role for the atypical PKC isoforms in nonassociative memory and cocaine
addiction.
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INTRODUCTION
Addiction involves long-lasting behavioral and neural changes
thought to render the addict chronically susceptible to relapse
(Robinson and Kolb, 1997; Robbins and Everitt, 1999; Nestler,
2001; Hyman et al., 2006; Koob and Volkow, 2010; Russo et al.,
2010; Lüscher andMalenka, 2011). Recently, it has been proposed
that the mechanisms of learning and memory, and addiction
overlap and that memory or memory-like neuronal remodel-
ing subserve addiction (Kelley, 2004; Kauer and Malenka, 2007;
Robinson and Berridge, 2008; Russo et al., 2010; Torregrossa et al.,
2011; Carmack et al., 2013).
In both processes, these changes involve the activation of
multiple protein kinases including CaMKIIα, PKA, and PKC
(Mayford, 2007; Lee and Messing, 2008; Kandel, 2012; Lisman
et al., 2012). Recently, there has been growing evidence specifi-
cally implicating atypical isoforms of PKC (aPKCs) in LTP and
memory (Pastalkova et al., 2006; Shema et al., 2007; Sacktor,
2008; Serrano et al., 2008; Ren et al., 2013). One isoform that
has received much attention is protein kinase Mζ (PKMζ). PKMζ
is persistently active and lacks the regulatory domain present on
most protein kinases, giving rise to the idea that PKMζ may be
essential for long-termmemory (LTM) and late long-term poten-
tiation (L-LTP). An abundance of studies implicating PKMζ in
LTM and L-LTP currently exists (Pastalkova et al., 2006; Shema
et al., 2007; Serrano et al., 2008; Kwapis et al., 2009, 2012; Parsons
and Davis, 2011). However, recent studies using PKCζ/PKMζ
knockout mice have questioned the idea that PKMζ is necessary
and sufficient for L-LTP and LTM and proposed that a second
atypical PKC isoform, PKCλ, is involved, especially in early stages
(Frankland and Josselyn, 2013; Lee et al., 2013; Matt and Hell,
2013; Ren et al., 2013; Volk et al., 2013).
Evidence implicating PKMζ in LTM and L-LTP comes from
studies using a single application of zeta-inhibitory peptide (ZIP)
or the more general PKC inhibitor chelerythrine (Herbert et al.,
1990; Yao et al., 2013). A few studies have used the dominant neg-
ative form of PKMζ to inhibit PKMζ and subsequently disrupt
LTP (Ling et al., 2002) and established memory (Shema et al.,
2007). Once believed to be selective to PKMζ, ZIP was recently
shown to also inhibit PKCλ (Ren et al., 2013). ZIP is derived from
the autoinhibitory pseudosubstrate segment of PKCζ, which is the
same as that of PKCλ (Standaert et al., 2001; Bosch et al., 2004).
Thus, the effects of ZIPmay result from PKMζ and/or PKCλ inhi-
bition. For the current studies, it is only important that plasticity
and associative memory are disrupted by ZIP.
While many prior studies have demonstrated the efficacy of
ZIP in impairing both associative memory and L-LTP (Pastalkova
et al., 2006; Shema et al., 2007; Serrano et al., 2008; Kwapis et al.,
2009; Parsons and Davis, 2011; Barry et al., 2012), the role of
aPKCs in addiction-related memory is unclear. We examined if
ZIP disrupts the nonassociative, addiction-related memory, psy-
chomotor sensitization to cocaine. Sensitization is an enhanced
sensitivity to a drug characterized by increased psychomotor
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activation (locomotor sensitization), increased dopamine release
(neural sensitization), and hypersensitivity to the drug’s reward-
ing value (incentive sensitization) and is used to model the transi-
tion from casual to compulsive drug use (Robinson and Berridge,
1993; Anagnostaras and Robinson, 1996; Anagnostaras et al.,
2002; Steketee and Kalivas, 2011; Shuman et al., 2012). Thus,
this memory is thought to reflect pathological and compulsive
behavior rather than ordinary associative learning.
Cocaine has been shown to change properties associated with
excitatory synaptic transmission. Both in slice and in vivo, alter-
ations in AMPAR/NMDAR ratios and increases in AMPAR rec-
tification have been demonstrated following cocaine treatment
(Kauer and Malenka, 2007; Kessels and Malinow, 2009). PKMζ
and PKCλ may exert their effects through AMPAR trafficking
(Ling et al., 2006; Yao et al., 2008; Migues et al., 2010; Sacktor,
2011; Ren et al., 2013). Perfusion of PKMζ into cells doubled the
AMPA mediated EPSC and inhibition of PKMζ decreased post-
synaptic GluR2 (Sacktor, 2008; Migues et al., 2010). Similarly,
PKCλ inhibition blocked the enhancement of GluA1/GluA2 typ-
ically induced by LTP suggesting the elevation of post-synaptic
AMPARs is dependent on PKCλ activity (Ren et al., 2013). Thus,
the aPKCs, PKMζ and PKCλ may also mediate modifications in
AMPARs during addiction-related memory and plasticity.
We examined the effects of disruption of aPKCs at multiple
time points during the induction of sensitization using continu-
ous or acute intracerebroventricular (ICV) application of ZIP or
chelerythrine. Finally, we examined whether acute disruption of
PKMζ reduced membrane-bound AMPAR density.
MATERIALS AND METHODS
ANIMALS
Ninety-six hybrid C57BL/6Jx129T2SvEms/J (129B6, Jackson
Labs) adult mice were used. Mice were group housed in a vivar-
ium on a 14:10 light:dark schedule. Testing was performed during
the light phase. All procedures were approved by the UCSD
IACUC and compliant with the NRC Guide.
DRUGS
The myristolated PKC Zeta pseudosubstrate inhibitory pep-
tide (AnaSpec) was dissolved in phosphate-buffered saline (PBS,
Ricca) to a dose of 10 nmol. In Experiment 1, 10 nmol of ZIP
was administered across 3 days at a rate of 0.25μL/hr whereas
in Experiments 3 and 4, the 10 nmol dose of ZIP was given in
a single 1μL infusion. Chelerythrine Cl (Enzo) was dissolved
in PBS to a concentration of 10 nmol/μL. Buprenorphine HCl
(0.05mg/kg, s.c.) was given for post-operative pain (Reckitt-
Benckiser). Cocaine HCl (Sigma) was dissolved in physiological
saline (salt weight, 15mg/kg, 10ml/kg, i.p.).
SURGERY
For all experiments mice were anesthetized with isoflurane dis-
pensed from a precision vaporizer and mounted in a stereotaxic
apparatus (myNeuroLab.com). A single hole was drilled in the
skull for infusion into the third ventricle (AP: −0.5mm; ML:
0mm, DV: −3mm, Franklin and Paxinos, 2007). Following
surgery, all animals were given an injection of buprenorphine.
For experiments examining continuous inhibition of aPKCs
(Experiments 1, 2), osmotic pumps (Alzet-Durect model 1002)
and PE60 tubing were implanted subcutaneously and connected
to an infusion headstage attached to the skull (Alzet, Brain infu-
sion kit 3).
Experiments 1 and 2
In Experiment 1, 16 h prior to surgery, pumps were filled with
aCSF (100μL; ion concentrations in mM: Na 150, K 3.0, Ca 1.4,
Mg 0.8, P 1.0, Cl 155; Harvard) and connected to tubing con-
taining ZIP and/or aCSF. A “leader” and “trailer” of aCSF was
placed before and after the ZIP in the tubing (separated with min-
eral oil) timed such that ZIP administration began 8.5 h prior to
the beginning of cocaine administration, and ended 23 h after the
sixth cocaine administration session (Figure 1A). In Experiment
2, pumps and tubing were filled with chelerythrine or aCSF.
Animals recovered for 3 days.
Experiments 3 and 4
In Experiment 3, mice were given one microinfusion of ZIP
prior to the induction of sensitization. Mice were implanted with
20-ga guide cannulae (PlasticsOne) 1mm above the target. A
dummy was placed inside the guide to prevent clogging. Animals
recovered for 3 days. Prior to ZIP infusion, mice were briefly
anaesthetized with isoflurane. Dummies were removed and a 24-
ga injection cannula that extended 1mm below the guide was
attached. ZIP was infused at a rate of 1μL/min using a syringe
pump (Kd Scientific) and injection cannulas were left in place
for 3min following the infusion. Animals recovered for 2 h. In
Experiment 4, after the induction of sensitization, mice were
given an infusion of ZIP or aCSF. A 29-ga stainless steel nee-
dle connected to a syringe and pump infused ZIP at a rate of
1μL/min. The needle remained in place for 3 additional min.
Animals recovered for 24 h.
BEHAVIORAL ASSESSMENT
Mice were tested in individual chambers housed in a window-
less room as described previously (Shuman et al., 2012; Carmack
et al., 2013). The apparatus consisted of a two-sided, 44 ×
44 × 31 cm chamber, bisected by an opaque wall with a remov-
able insert (Med-Associates). Sides assigned for drug and saline
pairings were counterbalanced. Activity monitor software (Med-
Associates) tracked the distance traveled. Two 100-watt bulbs lit
the room and white noise (65 dBA) played continuously. All ani-
mals were handled for 5 days prior to the experiments. Prior to
behavioral assessment, animals were habituated to the chambers
during two, 1 h sessions (30min each side).
Experiment 1
Mice were divided into four groups: Veh/Coc, ZIP/Coc, Veh/Veh,
ZIP/Veh (Figure 1A). Sensitization was induced during six ses-
sions of cocaine administration (2 sessions/day for 3 days).
Animals received an injection of saline (10ml/kg) and were
immediately placed in the saline-paired side of the chamber.
Animals were restricted to this side for 15min. Mice were then
removed, given an injection of cocaine (Veh/Veh and ZIP/Veh
mice received a second injection of saline) and restricted to
the drug-paired side of the chamber. After 15min, mice were
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FIGURE 1 | Continuous ZIP administration blocks cocaine-induced
locomotor sensitization. (A) Depiction of the procedure used in
experiment 1 (n = 10 Veh/Coc, n = 11 ZIP/Coc, n = 7 Veh/Veh, n = 8
ZIP/Veh). Mice were implanted with osmotic pumps, filled such that ZIP
would be delivered ICV just prior to the first cocaine administration session
and terminate 24 h following the sixth session (10 nmol, 0.25μL/h). Animals
underwent six cocaine administration sessions (2 sessions per day) during
which time the development and expression of sensitization was assessed.
(B) ZIP impaired the development of sensitization. The data represent the
average distance traveled for each session (±s.e.m.). The distance traveled
by mice receiving ZIP/Coc was reduced compared to mice treated with
Veh/Coc across the six cocaine administration sessions [15mg/kg, i.p.;
MANOVA, F(3, 32) = 18.3, p < 0.001; Fisher’s PLSD p < 0.05]. ZIP alone did
not produce any locomotor attenuating effects (ZIP/Veh, Veh/Veh, p = 0.93).
(C) ZIP did not alter the acute response to cocaine (session 1). Distance
traveled at each minute of the session (±s.e.m.) is shown. Animals receiving
cocaine (ZIP/Coc, Veh/Coc) traveled a greater distance compared to mice
receiving vehicle (ZIP/Veh, Veh/Veh, p < 0.05), but there was no difference
between the cocaine-treated groups (p = 0.78). (D) ZIP/Coc mice showed
reduced locomotor sensitization compared to Veh/Coc mice during session 6
[ANOVA, F(3, 32) = 16.7, p < 0.001; ZIP/Coc, Veh/Coc Fisher’s PLSD
p < 0.05]. Distance traveled at each minute of the session (±s.e.m.) is
shown. ZIP alone did not produce any effects on locomotor activity.
(E) Sensitization, measured as the difference between the sensitized
(session 6) and acute (session 1) responses, was blocked in ZIP/Coc mice.
The average difference in distance traveled (±s.e.m.) is shown for each
group. Sensitization in ZIP/Coc mice did not differ from mice treated with
ZIP/Veh or Veh/Veh (p > 0.1). (F) Sensitization was also assessed while all
animals were off-ZIP. ZIP/Coc and Veh/Coc groups showed greater activity
than mice that previously received vehicle [ZIP/Veh, Veh/Veh; MANOVA,
F(3, 32) = 3.2, p < 0.05]. Animals in the ZIP/Coc group showed reduced
sensitization compared to animals that had previously received Veh/Coc
during the first 5min of the test [ANOVA, F(3, 32) = 10.373, p < 0.001;
Fisher’s PLSD, ZIP/Coc vs. Veh/Coc, p < 0.05]. There were no differences in
the acute response to cocaine between animals that had not previously
received cocaine (Fisher’s PLSD, Veh/Veh, ZIP/Veh, p = 0.96).
removed from the chambers and returned to their home cages.
ZIP was infused continuously throughout the six cocaine admin-
istration sessions. Forty eight hours following the 6th cocaine
administration session, animals underwent a conditioned place
preference test. All animals were off-ZIP and off-drug. The insert
bisecting the two sides of the chamber was removed and ani-
mals were allowed to freely explore both sides of the chamber for
15min. Place preference wasmeasured as the difference in percent
time spent on the drug-paired side and saline-paired side. A
final, off-ZIP sensitization challenge test was conducted 24 h later.
All animals were given an injection of cocaine (15mg/kg) and
were immediately placed on the drug-paired side of the cham-
ber. Animals were restricted to the drug-paired side and remained
in the chambers for 15min. Sensitization was measured as the
increase in locomotor activity following repeated drug-context
pairings.
Frontiers in Behavioral Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 70 | 3
Howell et al. PKC and addiction
Experiment 2
Chelerythrine was delivered continuously throughout the entire
experiment. Procedures were the same as those described above;
however, in this experiment, animals were given five cocaine
administration sessions across 5 days, followed by a place pref-
erence test 24 h later and the sensitization challenge test another
24 h later (session 6).
Experiment 3
Mice were infused with ZIP (described above) 2 h prior to the first
cocaine administration session (session 1). 24 h later mice were
given an off-drug place preference test. Another 24 h later, mice
were given a sensitization challenge test (session 2).
Experiment 4
Animals were given four cocaine administration sessions across
4 days. 24 h after the final session, animals underwent surgery
and were infused with ZIP or vehicle (described above).
Following recovery, animals were given an off-drug place pref-
erence test followed 24 h later by a sensitization challenge test
(session 5).
HISTOLOGY
In Experiments 1 and 2 mice were anaesthetized and perfused
with 1 × PBS and 4% paraformaldehyde. Tissue was sliced into
1mm coronal sections using an acrylic matrix (Braintree). For
Experiments 3 and 4, animals were anesthetized and then decap-
itated for fresh tissue collection. Brains were extracted, frozen
in 2-methylbutene and stored at −80◦C. At −20◦C brains were
cut in 20μm coronal sections at 200μm intervals using a cryo-
stat (Microm HM550, Fisher). Cannula placement was verified
by visual inspection. Brain morphology remained grossly intact
following the application of ZIP and chelerythrine. No animals
were excluded.
RADIOLIGAND INCUBATION AND LIQUID SCINTILLATION
Optimal binding procedures for the [3H]AMPA radioligand are
adapted from previous literature (Olsen et al., 1987; Jang et al.,
2000; Monk et al., 2012). Sections were pre-incubated with
50mM Tris-HCl buffer for 20min, then incubated for 30min
with 15 nM [3H]AMPA (Sigma) in the same buffer at 25◦C. After
incubation, the sections were rinsed in the Tris-HCl buffer, then
washed in distilled water. Sections from each slide were trans-
ferred to vials containing a liquid scintillation cocktail (EcoLume
Liquid Scintillation Fluid,MPBiomedicals) to assess global AMPA
receptor expression density using automated liquid scintillation
(Tricarb 2900TR, PerkinElmer).
DATA ANALYSIS
Data were entered into a multivariate analysis of variance
(MANOVA; PASW18). The level of significance was set at p ≤
0.05. Following a significant omnibus comparison, or group x
time interaction, post-hoc comparisons were made using uni-
variate ANOVAs or Fisher’s protected least significant differ-
ence (PLSD). In order to simplify data presentation, univariate
ANOVAs are reported for group differences, followed by Fisher’s
PLSDs for interesting comparisons.
RESULTS
EXPERIMENT 1: EFFECTS OF CONTINUOUS ZIP ADMINISTRATION ON
LOCOMOTOR SENSITIZATION
We first examined the effects of continuous aPKC inhibition
on psychomotor sensitization to cocaine. Mice were implanted
with osmotic pumps that delivered continuous, ICV ZIP or aCSF
(10 nmol, 0.25μL/h) throughout six cocaine (15mg/kg, i.p.) or
saline administration sessions (Figures 1A,B). ZIP administra-
tion was timed such that it began prior to the first cocaine
administration session and ended after the sixth session. Mice
were divided into four groups (n = 7–11 per group): (1) Veh/Coc
mice received vehicle, ICV, in the pumps and i.p. cocaine injec-
tions, (2) ZIP/Coc mice were administered ZIP ICV through
pumps and received i.p. cocaine injections, (3) Veh/Veh mice
received vehicle both ICV and i.p., (4) ZIP/Veh mice received ICV
ZIP through the pumps, but received i.p. injections of vehicle. We
found an initial elevated locomotor response in groups receiv-
ing cocaine compared to those receiving vehicle, [Figure 1C;
ANOVA, F(3, 32) = 4.6, p = 0.009], but no difference in the acute
response to cocaine between ZIP/Coc mice and Veh/Coc mice
(Fisher’s PLSD, p = 0.78). Across the six sessions of cocaine
administration, differences between ZIP/Coc and Veh/Coc mice
emerged [Figures 1B,D,F; F(3, 32) = 18.3, p < 0.001]. ZIP/Coc
mice demonstrated a dramatic reduction in locomotor activ-
ity compared to Veh/Coc mice (p < 0.05). When paired with
saline, ZIP did not produce any locomotor attenuating effects
(ZIP/Veh vs. Veh/Veh, p = 0.93). We then measured sensitiza-
tion as the difference between the acute (session 1) and sensi-
tized (session 6) response (Shuman et al., 2012; Carmack et al.,
2013). There were significant group differences [F(3, 32) = 6.9,
p = 0.001; Figure 1E]; Veh/Coc mice exhibited robust sensitiza-
tion, showing a greater response than all other groups (p < 0.02).
Sensitization was blocked in ZIP/Coc mice, as they did not differ
from control groups (p > 0.1; Figure 1E). We conducted a final
sensitization challenge test, during which all animals were off-
ZIP and all groups received cocaine (15mg/kg, i.p.; Figure 1F).
Groups that had previously received cocaine (ZIP/Coc, Veh/Coc)
showed greater activity compared to groups that had previ-
ously received vehicle [ZIP/Veh, Veh/Veh; F(3, 32) = 3.2, p < 0.05;
Figure 1F], but ZIP/Coc mice showed attenuated sensitization
relative to Veh/Coc mice [first 5min, main effect, F(3, 32) = 10.4,
p < 0.001, ZIP/Coc vs. Veh/Coc, p < 0.05; Figure 1F].
EXPERIMENT 2: EFFECTS OF CONTINUOUS CHELERYTHRINE
ADMINISTRATION ON LOCOMOTOR SENSITIZATION
As we used a novel, chronic procedure to inhibit aPKCs, in
Experiment 2, we investigated whether continuous chelery-
thrine administration would affect sensitization similarly to
ZIP. Chelerythrine more generally blocks PKCs by competitively
inhibiting the catalytic domain and effectively inhibits PKM iso-
forms (Herbert et al., 1990; Serrano et al., 2008; Yao et al.,
2013). This experiment was conducted to validate the effective-
ness of using osmotic minipumps and continuous delivery to
inhibit aPKCs. Mice were implanted with osmotic pumps which
delivered chelerythrine or vehicle throughout the experiment at
a dose established by others (10 nmol/μL, 0.25μL/h, Serrano
et al., 2008; Yao et al., 2013). Mice were divided into two groups
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(n = 8–9 per group): (1) received chelerythrine (10 nmol/μL)
ICV as well as i.p. cocaine injections and (2) vehicle mice
received aCSF ICV and i.p. injections of cocaine. All animals
underwent six cocaine administration sessions (15mg/kg, i.p.;
Figure 2A). As with ZIP, chelerythrine did not affect the acute
response to cocaine during session 1 [F(1, 15) = 0.1, p = 0.76].
After the final cocaine administration session, sensitization was
assessed as the difference between the acute (session 1) and
sensitized response (session 6). Sensitization was dramatically
attenuated in mice previously treated with chelerythrine relative
to mice that had received vehicle [Figures 2B,C; F(1, 15) = 11.1,
p < 0.01].
EXPERIMENT 3: EFFECTS OF ACUTE, PRE-INDUCTION ZIP ON
LOCOMOTOR SENSITIZATION
As most previous studies have given a single infusion of ZIP
to assess the effects on memory, we examined if a single infu-
sion could disrupt sensitization (Pastalkova et al., 2006; Shema
et al., 2007; Serrano et al., 2008; Kwapis et al., 2009; Parsons and
Davis, 2011). In this experiment, we used two groups of mice
(n = 13 per group): (1) received a single pre-induction appli-
cation of ZIP (10 nmol/μL, 1μL) 2 h prior to the first cocaine
administration session, while (2) received a 1μL infusion of
aCSF prior to cocaine administration (Figure 3A). During this
initial session (15mg/kg, i.p.), ZIP did not affect the response
to cocaine [Figure 3A; F(1, 24) = 0.22, p = 0.65]. In contrast,
when challenged with cocaine while off-ZIP, 48 h later, mice
that had previously received ZIP showed substantial impairment
in sensitization [Figure 3A; F(1, 24) = 5.8, p < 0.05]. Further,
ZIP also impaired sensitization when assessed as the difference
in activity between the two sessions [Figure 3B; F(1, 24) = 5.7,
p < 0.05].
EXPERIMENT 4: EFFECTS OF ACUTE, POST-INDUCTION ZIP ON
LOCOMOTOR SENSITIZATION
We then examined whether a single, post-induction application
of ZIP could disrupt locomotor sensitization. Two groups of mice
were used (n = 8–9 per group); both groups received i.p. injec-
tions of cocaine (15mg/kg, i.p.), but one group received an ICV
infusion of ZIP while the other received an ICV infusion of aCSF.
Four cocaine administration sessions produced robust sensitiza-
tion that did not differ across groups [Figure 3C; F(1, 15) = 0.29,
p = 0.59]. After the fourth session, mice were given a single
microinfusion of ZIP (10 nmol/μL, 1μL) or a comparable infu-
sion of aCSF. Forty-eight hours later, we conducted an off-ZIP
sensitization test. Post-induction ZIP failed to affect sensitization
[Figure 3C; F(1, 15) = 0.23, p = 0.63].
EXPERIMENT 5: EFFECTS OF ZIP ON AMPAR DENSITY
Finally, we examined whether a single application of ZIP was suf-
ficient to reduce AMPAR density in sensitized brain tissue. As it
has been argued that both PKMζ and PKCλ exert their effects
through AMPAR trafficking (Ling et al., 2006; Yao et al., 2008;
Migues et al., 2010; Ren et al., 2013), we used a radioligand bind-
ing procedure to detect membrane-bound [3H]AMPA. We found
that membrane-bound AMPARs were significantly reduced in
tissue previously exposed to ZIP [Figure 3D; F(1, 34) = 6.2,
p < 0.02].
DISCUSSION
In the present study, we examined the effects of both continuous
and acute inhibition of the aPKC isoforms, PKMζ and PKCλ, on
the nonassociative, addiction-related memory, locomotor sensiti-
zation. There were two main findings. First, aPKCs are critically
involved in the development of locomotor sensitization; ZIP was
FIGURE 2 | Continuous chelerythrine reduces locomotor sensitization.
(A) Mice were implanted with osmotic pumps containing chelerythrine or
vehicle. Chelerythrine (n = 9 Chel, n = 8 Veh) was delivered continuously,
ICV (10 nmol/μL, 0.25μL/h), across six sessions of cocaine administration
(15mg/kg, i.p.). Average distance traveled (±s.e.m.) during each session is
depicted. Chelerythrine did not alter the acute response to cocaine [ANOVA,
F(1, 15) = 0.097, p = 0.76] but did reduce the development of sensitization
across the six sessions. (B) Sensitization, measured as the difference in
distance traveled between the acute (session 1) and sensitized (session 6)
response was significantly impaired in mice receiving chelerythrine across
15min [MANOVA, F(1, 15) = 11.1, p < 0.01]. The difference in distance
traveled (± s.e.m.) is shown for each minute. (C) Average sensitization
(±s.e.m.) measured as the difference in distance traveled is shown for each
group.
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FIGURE 3 | Single pre- but not post-induction application of ZIP
reduces locomotor sensitization. (A) Mice received a single pre-induction
infusion of ZIP (10 nmol/μL, 1μL). Sensitization was induced during two
sessions of cocaine administration (15mg/kg, i.p.). ZIP was administered
2 h prior to the first cocaine administration session (n = 13 ZIP, n = 13
aCSF), indicated by the arrow. The average distance traveled (±s.e.m.) for
each session is shown. While on-ZIP, the acute response to cocaine was
not altered [ANOVA, F(1, 24) = 0.215, p = 0.65]. Cocaine was given for a
second time, 48 h later, during session 2. When measured off-ZIP, distance
traveled was significantly reduced in animals that had previously received
ZIP [ANOVA, F(1, 24) = 5.8, p < 0.05]. (B) Sensitization was significantly
reduced in animals given ZIP prior to cocaine administration [ANOVA,
F(1, 24) = 5.7, p < 0.05]. Sensitization is represented as the average
difference in distance traveled (±s.e.m.) between the two sessions. (C)
Mice received a single post-induction infusion of ZIP (10 nmol/μL, 1μL).
Sensitization was induced across 4 sessions of cocaine administration
(15mg/kg, i.p.), after which mice were given a single infusion of ZIP,
represented by the arrow. Post-induction ZIP did not produce impairment
when sensitization was assessed 72 h later off-ZIP (ZIP n = 9, Veh n = 8).
(D) A single infusion of ZIP reduces AMPAR density following sensitization.
H3 counts (±s.e.m.) for each group are depicted.
highly effective at disrupting sensitization if infused prior to
cocaine administration. Second, infusion of ZIP after sensitiza-
tion had been established failed to produce impairment, despite
reducing the density of membrane-bound AMPARs. The current
findings extend the existing evidence regarding which forms of
memory are susceptible to disruption by ZIP. The novel method
for ZIP administration reveals nonassociative memory may have
different requirements for memory maintenance than traditional
forms of memory, as pre-induction ZIP was required to produce
impairment.
ZIP ADMINISTRATION DISRUPTS THE DEVELOPMENT OF
SENSITIZATION
Growing evidence supports the view that ZIP disrupts not only
PKMζ, but also a second atypical PKC isoform, PKCλ (Lee et al.,
2013; Ren et al., 2013; Volk et al., 2013). The majority of stud-
ies have used a single application to disrupt associative or spatial
forms of memory such as conditioned taste aversion, Pavlovian
fear conditioning, fear potentiated startle, and the Morris water
maze (Pastalkova et al., 2006; Shema et al., 2007; Serrano et al.,
2008; Kwapis et al., 2009; Parsons and Davis, 2011). ZIP is derived
from the pseudosubstrate sequence of PKCζ, which is identical to
that of PKCλ. At higher concentrations, ZIP inhibits both PKMζ
and PKCλ (Standaert et al., 2001; Bosch et al., 2004; Ren et al.,
2013). Here, we expand current findings to include a role for
PKMζ and PKCλ in the nonassociative, addiction-related mem-
ory, locomotor sensitization. Administration of either ZIP or
chelerythrine prior to induction impaired the development of
sensitization. ZIP dramatically impaired sensitization regardless
of whether it was given continuously or in a single infusion, but
the effects were largest when given continuously (Figures 1B,E).
Still, a single application of ZIP disrupted sensitization 48 h after
administration (Figures 3A,B), a time point when ZIP would
have been fully degraded (Kwapis et al., 2012). These results
demonstrate ZIP persistently effects sensitization if administra-
tion occurs prior to acquisition.
There are a few previous reports demonstrating ZIP’s ability to
disrupt certain forms of addiction-related plasticity and memory
including cocaine-induced spontaneous synaptic transmission,
the cocaine-induced enhancement in AMPA/NMDA ratio and
conditioned place preference (Li et al., 2011; Ho et al., 2012).
However, these studies focused on associative forms of addiction
related memory. The present study is the first to demonstrate
its ability to disrupt nonassociative addiction related memory.
Nonassociative aspects of addiction are important to consider as
they model key pathological components of what drive addiction.
ZIP DOES NOT IMPAIR THE MAINTENANCE OF SENSITIZATION
Studies that have examined the application of post-training ZIP
have found that it often produces amnesia (Pastalkova et al.,
2006; Shema et al., 2007; Serrano et al., 2008; Kwapis et al., 2009;
Gámiz and Gallo, 2011). However, Parsons and Davis (2011) sug-
gested the effects of ZIP were dependent on the timing between
training and administration. While memory and addiction have
been argued to share overlapping neural substrates (Robinson
and Kolb, 1997; Kelley, 2004; Kauer and Malenka, 2007; Lee and
Messing, 2008), findings from the current study suggest the role of
PKMζ and PKCλ in sensitization differs somewhat from their role
in associative memory. Once sensitization had been established,
ZIP administration was unable to produce subsequent impair-
ment (Figure 3C). Moreover, sustained inhibition was required
to fully prevent sensitization.
One possible reason that may account for these differences
is the region-specificity of the infusion. Most prior studies have
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infused ZIP into a particular region (e.g., amygdala, insular
cortex, hippocampus), however we administered ZIP ICV. It is
possible that the concentration of ZIP required to produce an
effect after sensitization had been established was not achieved.
Previous work has established that a certain concentration of
ZIP is required to block PKMζ and PKCλ and impair plasticity
(Serrano et al., 2005; Sacktor and Fenton, 2012; Ren et al., 2013).
A similar explanation could potentially account for differences in
the effects of ZIP on conditioned place preference found in this
study compared to other studies that have shown the apparent
erasure of CPP memory following the administration of PKMζ
inhibitors (Supplementary Figure S1, He et al., 2011; Li et al.,
2011; Shabashov et al., 2012; Lee et al., 2013). It is also possible
that by infusing ZIP ICV the peptide did not reach regions crit-
ical for the behavior, such as the amygdala (Everitt et al., 1991;
Hsu et al., 2002; He et al., 2011). While this explanation may
explain the negative result in our place preference experiments,
it likely does not account for our sensitization results because the
concentration achieved in the current study was sufficient to dis-
rupt sensitization prior to induction and produced a decrease in
AMPAR density when given post-induction.
An alternate reason we did not find an effect of ZIP on sen-
sitization when given after induction is that the mechanism of
ZIP may be different when given pre-training compared to post-
training. It is possible there is a shift to the right in the dose-effect
curve for ZIP given post- vs. pre-training. While we used the
standard dose of ZIP in the current study, in future studies, it
would be interesting to examine the effects of a higher dose
of ZIP on sensitization when given after induction; however, it
is possible there would be nonspecific effects at higher doses.
In the future it would be interesting to compare the effects of
a single post-induction ZIP infusion and continuous ZIP infu-
sion on AMPAR density. It is possible, in our experiments, that
continuous ZIP infusion reduced post-synaptic AMPAR density
below a critical threshold necessary to sustain memory, while
the single, post-induction infusion did not (despite using the
same total dose of ZIP). Similarly, it is also possible that inhibit-
ing aPKCs prior to training impairs AMPAR insertion or that
the newly inserted AMPARs are more vulnerable to the effects
of ZIP, potentially because of a difference in sub-unit composi-
tion. A more detailed analysis of the type of AMPARs affected
by pre- vs. post-training infusions could help to tease apart these
explanations. Another alternative is that the neural adaptations
produced by a nonassociative, drug-related memory may be more
enduring than those in associative memory or the mechanisms
may only partially overlap(Robinson and Kolb, 1997; Carmack
et al., 2013). A recent study conducted by Carmack and colleagues
(2013), using the NMDA receptor antagonist CPP, found that
NMDARs were not essential for the induction of sensitization,
whereas NMDARs were essential for the formation of place pref-
erence. A study conducted by Cai et al. (2011) was one of the few
studies to examine the effects of aPKC inhibition on nonasso-
ciative memory. In this study, both ZIP and chelerythrine were
found to disrupt long-term sensitization of the gill-withdrawal
reflex in Aplysia, even when given 7 days after training. While
both the current study and the Cai et al. study examine the
effects of inhibition of aPKCs on sensitization, the mechanisms
underlying each of these forms of sensitization is quite
different.
AMPAR trafficking is believed to mediate the downstream
effects of PKMζ and PKCλ (Ling et al., 2006; Yao et al., 2008;
Migues et al., 2010). PKMζ has been reported to enhance AMPA-
mediated mEPSCs and application of the synthetic peptide
GluR23Y effectively prevented the endocytosis of GluR2 AMPAR
subunits and prevented the deficit in fear memory typically pro-
duced by PKMζ inhibition (Ling et al., 2006; Migues et al., 2010).
Similarly, PKCλ also affects AMPAR trafficking. Inhibition of
PKCλ blocked the LTP-induced enhancement of post-synaptic
responses of GluA1 and GluA2 and post-synaptic AMPARs, mEP-
SCs, and EPSC magnitude are reduced by application of ZIP
or PKCλ knockdown (Ren et al., 2013). Our data support and
extend previous findings, which suggest the effects of PKMζ and
PKCλ are mediated by AMPARs, to cocaine-induced sensitiza-
tion. In future studies, an interesting comparison would be to
examine the effects of ZIP on both sensitized and nonsensitized
brain tissue, but for the purposes of this experiment we were
primarily concerned with any differences in AMPAR density in
cocaine-sensitized animals exposed to ZIP vs. nonZIP.
While ZIP was initially believed to exert its effects on plasticity
and memory by selectively inhibiting PKMζ, emerging evidence
suggests at concentrations of at least 2μM, the peptide acts on
PKCλ as well (Ren et al., 2013); this likely accounts for the con-
troversial findings obtained from mice with a deletion of the
Prkcz gene (Lee et al., 2013; Volk et al., 2013). ZIP still effectively
reversed LTP and cocaine-induced place preference in these mice
despite the absence of PKMζ (Lee et al., 2013; Volk et al., 2013).
Both lines of PKCζ/PKMζ knockout mice exhibit levels of PKCλ
that do not differ from controls (Lee et al., 2013; Volk et al., 2013).
We found that ZIP effectively impaired nonassociative addiction-
related memory and membrane-bound AMPAR expression, but
future work will be needed to directly assess the extent to which
ZIP exerts its effects on PKMζ, PKCλ or both atypical PKCs.
Additional future work will be needed to mitigate the discrepancy
between the post-training effects of ZIP on AMPAR density and
behavior. As mentioned above, it is possible that a higher dose of
ZIP is needed to disrupt AMPAR expression enough to disrupt
established sensitization. In the current study we examined global
AMPAR density, while future work will examine AMPAR density
in a region specific manner.
GENERAL CONCLUSION
In summary, we found that atypical PKC isoforms play a critical
role in cocaine-induced locomotor sensitization and addiction.
Future work should further explore the differences between tradi-
tional forms of associative memory and nonassociative addiction
related memory. These differences may elucidate how certain
forms of memorymay become pathological. Taken together, these
findings support a critical role for the atypical PKCs, PKMζ, and
PKCλ in cocaine-induced sensitization and therefore in mediat-
ing the transition from casual to pathological drug use.
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SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://www.frontiersin.org/journal/10.3389/fnbeh.2014.
00070/abstract
We conducted a place preference test following training for
each of the experiments. We did not however explore the effects
of ZIP while on-board during place preference. Thus, we cannot
make any strong conclusions regarding the effects of ZIP on place
preference.
Supplementary Figure S1 | Conditioned place preference assessment. (A)
Place preference was examined for all experiments. In Experiment 1 mice
that had previously received cocaine (Veh/Coc, ZIP/Coc) showed place
preference whereas mice that had received vehicle (Veh/Veh, ZIP/Veh) did
not [F(3, 32) = 15.048, p < 0.01]. Continuous ZIP did not affect place
preference (Veh/Coc, ZIP/Coc, p = 0.45). (B) Experiment 2. Chelerythrine
did not disrupt place preference [F(1, 15) = 3.121, p = 0.10]. (C) An
infusion of ZIP given prior to any cocaine administration did not impair
place preference [F(1, 15) = 1.440, p = 0.24]. (D) Place preference
remained intact when ZIP was given after the induction of sensitization
[F(1, 15) = 0.023, p = 0.88].
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